NO942781L - Fremgangsmåte for inaktivering av virale og bakterielle blodforurensninger - Google Patents

Fremgangsmåte for inaktivering av virale og bakterielle blodforurensninger

Info

Publication number
NO942781L
NO942781L NO942781A NO942781A NO942781L NO 942781 L NO942781 L NO 942781L NO 942781 A NO942781 A NO 942781A NO 942781 A NO942781 A NO 942781A NO 942781 L NO942781 L NO 942781L
Authority
NO
Norway
Prior art keywords
inactivating viral
bacterial blood
blood contaminants
inactivating
viral
Prior art date
Application number
NO942781A
Other languages
English (en)
Norwegian (no)
Other versions
NO942781D0 (no
Inventor
Jr Raymond P Goodrich
Nagendar Yerram
Roger W Hackett
Marjan Van Borssum Waalkes
Original Assignee
Cryopharm Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cryopharm Corp filed Critical Cryopharm Corp
Publication of NO942781D0 publication Critical patent/NO942781D0/no
Publication of NO942781L publication Critical patent/NO942781L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
NO942781A 1992-01-27 1994-07-26 Fremgangsmåte for inaktivering av virale og bakterielle blodforurensninger NO942781L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82569192A 1992-01-27 1992-01-27
PCT/US1993/000401 WO1993014791A2 (en) 1992-01-27 1993-01-27 Method of inactivation of viral and bacterial blood contaminants

Publications (2)

Publication Number Publication Date
NO942781D0 NO942781D0 (no) 1994-07-26
NO942781L true NO942781L (no) 1994-09-15

Family

ID=25244689

Family Applications (1)

Application Number Title Priority Date Filing Date
NO942781A NO942781L (no) 1992-01-27 1994-07-26 Fremgangsmåte for inaktivering av virale og bakterielle blodforurensninger

Country Status (10)

Country Link
EP (1) EP0633786B1 (ja)
JP (1) JP2001509773A (ja)
AT (1) ATE203679T1 (ja)
AU (1) AU3476593A (ja)
CA (1) CA2128866A1 (ja)
DE (1) DE69330514T2 (ja)
IL (1) IL104530A0 (ja)
NO (1) NO942781L (ja)
WO (1) WO1993014791A2 (ja)
ZA (1) ZA93587B (ja)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6077659A (en) * 1990-05-15 2000-06-20 New York Blood Center, Inc. Vitamin E and derivatives thereof prevent potassium ion leakage and other types of damage in red cells that are virus sterilized by phthalocyanines and light
US5578486A (en) * 1994-08-05 1996-11-26 International Tlb Research Institute, Inc. Recombinant microbial fertilizer and methods for its production
AU691672B2 (en) * 1994-09-22 1998-05-21 Baxter International Inc. Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers
BR9608776A (pt) * 1995-05-19 2000-10-24 New York Blood Ct Inc Processo de uso de ftalocianinas para inativar parasitas do sangue
WO1997036581A1 (en) * 1996-03-29 1997-10-09 Therakos, Inc. Photopheresis treatment of leukocytes
EP0892599A4 (en) 1996-04-09 2001-05-16 Therakos Inc PROCESS FOR THE ELIMINATION OF PSORALENES IN BIOLOGICAL FLUIDS
AT405608B (de) * 1997-04-08 1999-10-25 Immuno Ag Verfahren zur inaktivierung von pathogenen, insbesondere von viren, in einem biologischen material
CA2285935C (en) 1997-04-08 2011-01-18 Baxter Aktiengesellschaft An immunotolerant prothrombin complex preparation
IL133913A0 (en) * 1997-07-10 2001-04-30 Therakos Inc Treatment of inflammatory disorders of the bowel and urinary bladder
DE69826521T2 (de) * 1998-01-06 2005-09-29 Cerus Corp., Concord Verfahren zum quenchen von pathogen-inaktivatoren in biologischen materialien
US7049140B1 (en) 1999-04-29 2006-05-23 Vanderbilt University X-ray guided drug delivery
US6159443A (en) * 1999-04-29 2000-12-12 Vanderbilt University X-ray guided drug delivery
US6219584B1 (en) 1999-07-09 2001-04-17 Therakos, Inc. Method and system for determining an effective amount of light energy to delivery to fluids having targets for the light energy
US6495366B1 (en) 1999-09-03 2002-12-17 Therakos, Inc. Uninterrupted flow pump apparatus and method
US7306925B2 (en) 2001-11-09 2007-12-11 Vanderbilt University Phage antibodies to radiation-inducible neoantigens
US7906102B2 (en) 2001-10-03 2011-03-15 Vanderbilt University Ligands to radiation-induced molecules
WO2013019730A1 (en) 2011-07-29 2013-02-07 The Washington University Antibodies to tip-1 and grp78
WO2014194931A1 (en) 2013-06-03 2014-12-11 Onderzoeks- En Ontwikkelingsfonds Rode Kruis-Vlaanderen Pathogen reduction treatment
WO2016014939A1 (en) 2014-07-24 2016-01-28 Washington University Compositions targeting radiation-induced molecules and methods of use thereof
WO2018148595A1 (en) 2017-02-10 2018-08-16 Washington University Antibodies to tip1 and methods of use thereof
WO2021074970A1 (ja) * 2019-10-15 2021-04-22 株式会社日立ハイテク 核酸試料処理装置および核酸試料処理方法
IL309030A (en) * 2021-06-14 2024-02-01 St Andrews Pharmaceutical Tech Ltd A device for improving hydration and/or reducing the particle size of a product and a method of using it

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4305390A (en) * 1975-11-28 1981-12-15 Massachusetts Institute Of Technology Method for generating oxygen in an excited electronic state and inactivation of microorganisms
SU959786A1 (ru) * 1980-04-17 1982-09-23 Московский технологический институт мясной и молочной промышленности Способ консервировани цельной крови
US4684521A (en) * 1982-12-08 1987-08-04 Frederic A. Bourke, Jr. Method and system for externally treating the blood
DE3483751D1 (de) * 1983-05-02 1991-01-31 Diamond Scient Co Photochemische entkeimungsbehandlung von vollem blut oder blutbestandteilen.
US4748120A (en) * 1983-05-02 1988-05-31 Diamond Scientific Co. Photochemical decontamination treatment of whole blood or blood components
JPS61275228A (ja) * 1985-03-14 1986-12-05 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド 治療用タンパク組成物中のビ−ルスの光動的不活性化
WO1991016060A1 (en) * 1990-04-16 1991-10-31 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5120649A (en) * 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
AU650998B2 (en) * 1991-06-21 1994-07-07 Baxter International Inc. Method for inactivating pathogens in a body fluid

Also Published As

Publication number Publication date
DE69330514T2 (de) 2002-03-28
WO1993014791A3 (en) 2000-02-17
JP2001509773A (ja) 2001-07-24
EP0633786A1 (en) 1995-01-18
ATE203679T1 (de) 2001-08-15
DE69330514D1 (de) 2001-09-06
CA2128866A1 (en) 1993-08-05
ZA93587B (en) 1994-07-07
NO942781D0 (no) 1994-07-26
AU3476593A (en) 1993-09-01
WO1993014791A2 (en) 1993-08-05
EP0633786A4 (en) 1995-04-19
EP0633786B1 (en) 2001-08-01
IL104530A0 (en) 1993-05-13

Similar Documents

Publication Publication Date Title
NO942781D0 (no) Fremgangsmåte for inaktivering av virale og bakterielle blodforurensninger
EP0483304A4 (en) Method of inactivation of viral and bacterial blood contaminants
NO913013D0 (no) Fremgangsmaate for kjemisk behandling av slam og vaesker.
FR2553665B1 (fr) Recipient de sterilisation
ATE71095T1 (de) Azolylmethyloxirane - ihre herstellung und verwendung als pflanzenschutzmittel.
FI960281A (fi) Menetelmä tuotteiden sterilisoimiseksi
AU3363689A (en) Blood processing apparatus
DK545786A (da) Hidtil ukendte insulinderivater og farmaceutiske praeparater, som indeholder disse derivater
ATE176326T1 (de) Gelkassette für eine verbesserte elektroforetische trennung und verfahren zu deren herstellung
IT7925568A0 (it) Composizione adatta al controllo di tessuti e/o liquidi biologici emetodo impiegante la stessa.
CA2056619A1 (en) Method of inactivation of viral and bacterial blood contaminants
FI854395A (fi) Sv40-expressionsvektor innehaollande hbxag-antigen som expressionsmarkering.
DK159114C (da) Benzyldihydrofuropyridinderivater og praeparater indeholdende disse forbindelser
ATE170709T1 (de) Verwendung von l-carnitin und alkanoyl l- carnitine zum bewahren von transfusionsblut, und sie enthaltenden stabilisierungslösungen
DK479788D0 (da) Fremgangsmaade til maerkning af stoffer med technetium- eller rheniumisotoper samt de maerkede stoffers anvendelse
ATE329603T1 (de) Implantat mit immunisolierten stromazellen und deren verwendung
DE3677092D1 (de) Emulsionen zur entseuchung giftiger, chemischer mittel, deren herstellung und verwendung.
DE3776170D1 (de) Quelle ultravioletter strahlen und verwendung derselben in verfahren mit photochemischer reaktion.
IT7924779A0 (it) Impianto per la sterilizzazione di liquidi in genere mediante radiazioni ultraviolette e relativo procedimento.
DE3585049D1 (de) Monoklonale antikoerper.
ATE70181T1 (de) Verwendung von oxochinazolinderivaten bei der behandlung von hyperurikaemie.
DK560889A (da) Lysozymgen fra streptomycesarter, deri indgaaende oligonukleotidsonde samt hybridvektor og mikroorganismer indeholdende det
NO872223D0 (no) Bakteriociner og preparater inneholdende disse for anti-virus behandling.
ES2072331T3 (es) Procedimiento para la descontaminacion de cultivos celulares que contienen micoplasmas.
NO159648C (no) Apparat og fremgangsmaate for sterilisering av beholdere.